Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients

Clinical Nephrology

Volumn 68, Issue 4, 2007, Pages 222-227

  Ishimura, E ^a   Okuno, S ^b   Kitatani, K ^b   Tsuchida, T ^a   Yamakawa, T ^b   Shioi, A ^a   Inaba, M ^a   Nishizawa, Y ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Shirasagi Hospital Kidney Center   (Japan)

Author keywords

Hemodialysis patients; Serum magnesium; Vascular calcification

Indexed keywords

BICARBONATE; CALCIUM; DIALYSIS FLUID; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL CALCIFICATION; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HAND RADIOGRAPHY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOMAGNESEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; SEX DIFFERENCE; TREATMENT DURATION;

EID: 34948885248     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp68222     Document Type: Article

References (25)

1. Agus MS, Agus ZS. Cardiovascular actions of magnesium. Crit Care Clin. 2001; 17: 175-186.
2. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res. 1995; 41: 347-359.
3. Bennett RM, Lehr JR, McCarty DJ. Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. J Clin Invest. 1975; 56: 1571-1579.
4. Calo L, Punzi L, Semplicini A. 2000 Hypomagnesemia and chondrocalcinosis in Bartter's and Gitelman's syndrome: review of the pathogenetic mechanisms. Am J Nephrol. 1975; 20: 347-350.
5. Cozzolino M, Dusso AS, Slatopolsky E. 2001 Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol. 2001; 12: 2511-2516.
6. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 2001; 60: 472-479.
7. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H. Vascular calcification and inorganic phosphate. Am J Kidney Dis. 2001; 38: 34-37.
8. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Meal. 2000; 342: 1478-1483.
9. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984; 108: 188-193.
10. Ishimura E, Okuno S, Kitatani K, Kim M, Shoji T, Nakatani T, Inaba M, Nishizawa Y. Different risk factors for peripheral vascular calcification between diabetic and nondiabetic hemodialysis patients - importance of glycemic control. Diabetologia 2002; 45: 1446-1448.
11. Ishimura E, Okuno S, Kitatani K, Maekawa K, Izumotani T, Yamakawa T, Jono S, Shoji T, Shioi A, Inaba M, Massry SG, Nishizawa Y. C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Semin Nephrol. 2004; 24: 408-412.
12. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complication in noninsulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996; 16: 978-983.
13. Liao F, Folsom AR, Brancati FL. 1998 Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1998; 136: 480-490.
14. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003; 18: 1731-1740.
15. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995; 48: 927-940.
16. Meema HE, Oreopoulos DG, Rapoport A. Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int. 1987; 32: 388-394.
17. Navarro JF, Mora C, Macia M, Garcia J. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Petit Dial Int. 1999; 19: 455-461.
18. Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis. 1999; 34: 43-48.
19. Navarro JF, Macia ML, Gallego E, Mendez ML, Chahin J, Garcia-Nieto V, Garcia JJ. Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol. 1997; 31: 275-280.
20. O'Hare AM, Hsu CY, Bacchetti P, Johansen KL. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol. 2002; 13: 497-503.
21. Richette P, Ayoub G, Bardin T, Bouvet S, Orcel P, Badran AM. Hypomagnesemia and chondrocalcinosis in short bowel syndrome. Rheumatol. 2005; 32: 2434-2436.
22. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W. The serum protein alpha2-Heremans-Schmid glycoprotein/fetuin A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003; 112: 357-366.
23. Schwille PO, Schmiedl A, Schwille R, Brunner P, Kissler H, Cesnjevar R, Gepp H. Media calcification, low erythrocyte magnesium, altered plasma magnesium and calcium homeostasis following grafting of the thoracic aorta to the infrarenal aorta in the rat - differential preventive effects of long-term oral magnesium supplementation alone and in combination with alkali. Biomed Pharmacother. 2003; 57: 88-97.
24. Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D, Kallivretakis N. Mitral annular calcifications in hemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant. 1997; 12: 2036-2037.
25. van den Broek FA, Beems RB, van Tintelen G, Lemmens AG, Fielmich-Bouwman AX Beynen AC. Covariance of chemically and histologically analysed severity of dystrophic cardiac calcification in mice. Lab Anim. 1997; 31: 74-80.